Sphere Fluidics to Globally Launch New Cyto-Mine Platform at BIO2014

Sphere Fluidics will be launching its vision for development of its’ new Cyto-Mine platform at BIO2014 (being held in San Diego during June 23rd-26th 2014). Dr Frank F. Craig (CEO), Dr Marian Rehak (Director of R&D) and Dr Rob Marchmont (Commercial Director) will be attending. “This new system will perform novel single cell and cell:cell or cell:biomolecule assays on millions of cells and also ensure enhanced monoclonality of isolated “hits.” said Dr Rehak. “This new platform will accelerate biopharmaceutical discovery and development. We are also now starting to collaborate with leading biopharmaceutical companies to help shape the features of this exciting new platform.” said Dr Marchmont. “We will also be exhibiting at Booth #3317 in the UK Pavilion and are meeting a number of top firms for biopartnering discussions, so this will be an excellent meeting for Sphere Fluidics.” said Dr Craig. More information can be found here.